According to A Latest intelligence report published by Market IntelliX, the global market for Transcriptome Sequencing should grow from US$ 1925.5 million in 2022 to US$ 5532.8 million by 2029, with a CAGR of 16.6% for the period of 2023-2029.
The key service providers of Transcriptome Sequencing in the world are Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences and Eurofins Scientific, among which the top five providers account for more than 70% of the market share, and Illumina is the largest service provider. The global transcriptome sequencing service providers are mainly distributed in North America, Europe, China and Japan, among which the market share of the top three regions is close to 80%. At present, North America is the largest service provider region. In terms of its service type, the growth rate of noncoding RNA is relatively fast. At present, the market share of coding RNA is high, close to 80%. In terms of its application, biomedicine is the largest application field, with a market share of more than 85%, followed by non-medical fields.
This report aims to provide a comprehensive study of the global market for Transcriptome Sequencing. Report Highlights:
(1) Global Transcriptome Sequencing market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Transcriptome Sequencing market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Transcriptome Sequencing market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Transcriptome Sequencing segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Transcriptome Sequencing segment by type and by application and regional segment by type and by application.
(6) Transcriptome Sequencing industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Coding RNA
Noncoding RNA
Market segment by application, can be divided into
Biomedical Field
Non-medical Field
Market segment by players, this report covers
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Genomics
Zhijiang Biology
Novogene Co., Ltd
Macrogen
Tsingke Biotechnology Co., Ltd.
1 Market Overview
1.1 Product Overview and Scope of Transcriptome Sequencing
1.2 Global Transcriptome Sequencing Market Size and Forecast
1.3 China Transcriptome Sequencing Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Transcriptome Sequencing Share in Global Market, 2018-2029
1.4.2 Transcriptome Sequencing Market Size: China VS Global, 2018-2029
1.5 Transcriptome Sequencing Market Dynamics
1.5.1 Transcriptome Sequencing Market Drivers
1.5.2 Transcriptome Sequencing Market Restraints
1.5.3 Transcriptome Sequencing Industry Trends
1.5.4 Transcriptome Sequencing Industry Policy
2 Global Competitive Situation by Company
2.1 Global Transcriptome Sequencing Revenue by Company (2018-2023)
2.2 Global Transcriptome Sequencing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Transcriptome Sequencing Concentration Ratio
2.4 Global Transcriptome Sequencing Mergers & Acquisitions, Expansion Plans
2.5 Global Transcriptome Sequencing Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Transcriptome Sequencing Revenue by Company (2018-2023)
3.2 China Transcriptome Sequencing Transcriptome Sequencing Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Transcriptome Sequencing, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Transcriptome Sequencing Industry Chain
4.2 Transcriptome Sequencing Upstream Analysis
4.3 Transcriptome Sequencing Midstream Analysis
4.4 Transcriptome Sequencing Downstream Analysis
5 Sights by Type
5.1 Transcriptome Sequencing Classification
5.1.1 Coding RNA
5.1.2 Noncoding RNA
5.2 By Type, Global Transcriptome Sequencing Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Transcriptome Sequencing Revenue, 2018-2029
6 Sights by Application
6.1 Transcriptome Sequencing Segment by Application
6.1.1 Biomedical Field
6.1.2 Non-medical Field
6.2 By Application, Global Transcriptome Sequencing Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Transcriptome Sequencing Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Transcriptome Sequencing Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Transcriptome Sequencing Market Size, 2018-2029
7.3 North America
7.3.1 North America Transcriptome Sequencing Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Transcriptome Sequencing Market Size Market Share
7.4 Europe
7.4.1 Europe Transcriptome Sequencing Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Transcriptome Sequencing Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Transcriptome Sequencing Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Transcriptome Sequencing Market Size Market Share
7.6 South America
7.6.1 South America Transcriptome Sequencing Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Transcriptome Sequencing Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Transcriptome Sequencing Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Transcriptome Sequencing Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Transcriptome Sequencing Market Size, 2018-2029
8.3.2 By Company, U.S. Transcriptome Sequencing Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Transcriptome Sequencing Market Size, 2018-2029
8.4.2 By Company, Europe Transcriptome Sequencing Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Transcriptome Sequencing Market Size, 2018-2029
8.5.2 By Company, China Transcriptome Sequencing Revenue Market Share, 2018-2023
8.5.3 By Type, China Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Transcriptome Sequencing Market Size, 2018-2029
8.6.2 By Company, Japan Transcriptome Sequencing Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Transcriptome Sequencing Market Size, 2018-2029
8.7.2 By Company, South Korea Transcriptome Sequencing Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Transcriptome Sequencing Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Transcriptome Sequencing Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Transcriptome Sequencing Market Size, 2018-2029
8.9.2 By Company, India Transcriptome Sequencing Revenue Market Share, 2018-2023
8.9.3 By Type, India Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Transcriptome Sequencing Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Transcriptome Sequencing Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Illumina
9.1.1 Illumina Company Information, Head Office, Market Area and Industry Position
9.1.2 Illumina Company Profile and Main Business
9.1.3 Illumina Transcriptome Sequencing Models, Specifications and Application
9.1.4 Illumina Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.1.5 Illumina Recent Developments
9.2 Thermo Fisher Scientific
9.2.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
9.2.2 Thermo Fisher Scientific Company Profile and Main Business
9.2.3 Thermo Fisher Scientific Transcriptome Sequencing Models, Specifications and Application
9.2.4 Thermo Fisher Scientific Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.2.5 Thermo Fisher Scientific Recent Developments
9.3 Bio-Rad
9.3.1 Bio-Rad Company Information, Head Office, Market Area and Industry Position
9.3.2 Bio-Rad Company Profile and Main Business
9.3.3 Bio-Rad Transcriptome Sequencing Models, Specifications and Application
9.3.4 Bio-Rad Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.3.5 Bio-Rad Recent Developments
9.4 Agilent Technologies
9.4.1 Agilent Technologies Company Information, Head Office, Market Area and Industry Position
9.4.2 Agilent Technologies Company Profile and Main Business
9.4.3 Agilent Technologies Transcriptome Sequencing Models, Specifications and Application
9.4.4 Agilent Technologies Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.4.5 Agilent Technologies Recent Developments
9.5 QIAGEN
9.5.1 QIAGEN Company Information, Head Office, Market Area and Industry Position
9.5.2 QIAGEN Company Profile and Main Business
9.5.3 QIAGEN Transcriptome Sequencing Models, Specifications and Application
9.5.4 QIAGEN Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.5.5 QIAGEN Recent Developments
9.6 Roche
9.6.1 Roche Company Information, Head Office, Market Area and Industry Position
9.6.2 Roche Company Profile and Main Business
9.6.3 Roche Transcriptome Sequencing Models, Specifications and Application
9.6.4 Roche Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.6.5 Roche Recent Developments
9.7 Pacific Biosciences
9.7.1 Pacific Biosciences Company Information, Head Office, Market Area and Industry Position
9.7.2 Pacific Biosciences Company Profile and Main Business
9.7.3 Pacific Biosciences Transcriptome Sequencing Models, Specifications and Application
9.7.4 Pacific Biosciences Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.7.5 Pacific Biosciences Recent Developments
9.8 Eurofins Scientific
9.8.1 Eurofins Scientific Company Information, Head Office, Market Area and Industry Position
9.8.2 Eurofins Scientific Company Profile and Main Business
9.8.3 Eurofins Scientific Transcriptome Sequencing Models, Specifications and Application
9.8.4 Eurofins Scientific Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.8.5 Eurofins Scientific Recent Developments
9.9 Azenta
9.9.1 Azenta Company Information, Head Office, Market Area and Industry Position
9.9.2 Azenta Company Profile and Main Business
9.9.3 Azenta Transcriptome Sequencing Models, Specifications and Application
9.9.4 Azenta Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.9.5 Azenta Recent Developments
9.10 LabCorp
9.10.1 LabCorp Company Information, Head Office, Market Area and Industry Position
9.10.2 LabCorp Company Profile and Main Business
9.10.3 LabCorp Transcriptome Sequencing Models, Specifications and Application
9.10.4 LabCorp Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.10.5 LabCorp Recent Developments
9.11 BGI Genomics
9.11.1 BGI Genomics Company Information, Head Office, Market Area and Industry Position
9.11.2 BGI Genomics Company Profile and Main Business
9.11.3 BGI Genomics Transcriptome Sequencing Models, Specifications and Application
9.11.4 BGI Genomics Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.11.5 BGI Genomics Recent Developments
9.12 Zhijiang Biology
9.12.1 Zhijiang Biology Company Information, Head Office, Market Area and Industry Position
9.12.2 Zhijiang Biology Company Profile and Main Business
9.12.3 Zhijiang Biology Transcriptome Sequencing Models, Specifications and Application
9.12.4 Zhijiang Biology Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.12.5 Zhijiang Biology Recent Developments
9.13 Novogene Co., Ltd
9.13.1 Novogene Co., Ltd Company Information, Head Office, Market Area and Industry Position
9.13.2 Novogene Co., Ltd Company Profile and Main Business
9.13.3 Novogene Co., Ltd Transcriptome Sequencing Models, Specifications and Application
9.13.4 Novogene Co., Ltd Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.13.5 Novogene Co., Ltd Recent Developments
9.14 Macrogen
9.14.1 Macrogen Company Information, Head Office, Market Area and Industry Position
9.14.2 Macrogen Company Profile and Main Business
9.14.3 Macrogen Transcriptome Sequencing Models, Specifications and Application
9.14.4 Macrogen Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.14.5 Macrogen Recent Developments
9.15 Tsingke Biotechnology Co., Ltd.
9.15.1 Tsingke Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
9.15.2 Tsingke Biotechnology Co., Ltd. Company Profile and Main Business
9.15.3 Tsingke Biotechnology Co., Ltd. Transcriptome Sequencing Models, Specifications and Application
9.15.4 Tsingke Biotechnology Co., Ltd. Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
9.15.5 Tsingke Biotechnology Co., Ltd. Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Transcriptome Sequencing Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Transcriptome Sequencing Market Restraints
Table 3. Transcriptome Sequencing Market Trends
Table 4. Transcriptome Sequencing Industry Policy
Table 5. Global Transcriptome Sequencing Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Transcriptome Sequencing Revenue Market Share by Company (2018-2023)
Table 7. Global Transcriptome Sequencing Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Transcriptome Sequencing Mergers & Acquisitions, Expansion Plans
Table 9. Global Transcriptome Sequencing Manufacturers Product Type
Table 10. China Transcriptome Sequencing Revenue by Company (2018-2023) & (US$ million)
Table 11. China Transcriptome Sequencing Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Transcriptome Sequencing Upstream (Raw Materials)
Table 13. Global Transcriptome Sequencing Typical Customers
Table 14. Transcriptome Sequencing Typical Distributors
Table 15. By Type, Global Transcriptome Sequencing Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Transcriptome Sequencing Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Transcriptome Sequencing Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Transcriptome Sequencing Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Transcriptome Sequencing Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Transcriptome Sequencing Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Transcriptome Sequencing Revenue Market Share, 2018-2029
Table 22. Illumina Company Information, Head Office, Market Area and Industry Position
Table 23. Illumina Company Profile and Main Business
Table 24. Illumina Transcriptome Sequencing Models, Specifications and Application
Table 25. Illumina Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 26. Illumina Recent Developments
Table 27. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 28. Thermo Fisher Scientific Company Profile and Main Business
Table 29. Thermo Fisher Scientific Transcriptome Sequencing Models, Specifications and Application
Table 30. Thermo Fisher Scientific Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 31. Thermo Fisher Scientific Recent Developments
Table 32. Bio-Rad Company Information, Head Office, Market Area and Industry Position
Table 33. Bio-Rad Company Profile and Main Business
Table 34. Bio-Rad Transcriptome Sequencing Models, Specifications and Application
Table 35. Bio-Rad Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 36. Bio-Rad Recent Developments
Table 37. Agilent Technologies Company Information, Head Office, Market Area and Industry Position
Table 38. Agilent Technologies Company Profile and Main Business
Table 39. Agilent Technologies Transcriptome Sequencing Models, Specifications and Application
Table 40. Agilent Technologies Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 41. Agilent Technologies Recent Developments
Table 42. QIAGEN Company Information, Head Office, Market Area and Industry Position
Table 43. QIAGEN Company Profile and Main Business
Table 44. QIAGEN Transcriptome Sequencing Models, Specifications and Application
Table 45. QIAGEN Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 46. QIAGEN Recent Developments
Table 47. Roche Company Information, Head Office, Market Area and Industry Position
Table 48. Roche Company Profile and Main Business
Table 49. Roche Transcriptome Sequencing Models, Specifications and Application
Table 50. Roche Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 51. Roche Recent Developments
Table 52. Pacific Biosciences Company Information, Head Office, Market Area and Industry Position
Table 53. Pacific Biosciences Company Profile and Main Business
Table 54. Pacific Biosciences Transcriptome Sequencing Models, Specifications and Application
Table 55. Pacific Biosciences Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 56. Pacific Biosciences Recent Developments
Table 57. Eurofins Scientific Company Information, Head Office, Market Area and Industry Position
Table 58. Eurofins Scientific Company Profile and Main Business
Table 59. Eurofins Scientific Transcriptome Sequencing Models, Specifications and Application
Table 60. Eurofins Scientific Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 61. Eurofins Scientific Recent Developments
Table 62. Azenta Company Information, Head Office, Market Area and Industry Position
Table 63. Azenta Company Profile and Main Business
Table 64. Azenta Transcriptome Sequencing Models, Specifications and Application
Table 65. Azenta Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 66. Azenta Recent Developments
Table 67. LabCorp Company Information, Head Office, Market Area and Industry Position
Table 68. LabCorp Company Profile and Main Business
Table 69. LabCorp Transcriptome Sequencing Models, Specifications and Application
Table 70. LabCorp Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 71. LabCorp Recent Developments
Table 72. BGI Genomics Company Information, Head Office, Market Area and Industry Position
Table 73. BGI Genomics Company Profile and Main Business
Table 74. BGI Genomics Transcriptome Sequencing Models, Specifications and Application
Table 75. BGI Genomics Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 76. BGI Genomics Recent Developments
Table 77. Zhijiang Biology Company Information, Head Office, Market Area and Industry Position
Table 78. Zhijiang Biology Company Profile and Main Business
Table 79. Zhijiang Biology Transcriptome Sequencing Models, Specifications and Application
Table 80. Zhijiang Biology Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 81. Zhijiang Biology Recent Developments
Table 82. Novogene Co., Ltd Company Information, Head Office, Market Area and Industry Position
Table 83. Novogene Co., Ltd Company Profile and Main Business
Table 84. Novogene Co., Ltd Transcriptome Sequencing Models, Specifications and Application
Table 85. Novogene Co., Ltd Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 86. Novogene Co., Ltd Recent Developments
Table 87. Macrogen Company Information, Head Office, Market Area and Industry Position
Table 88. Macrogen Company Profile and Main Business
Table 89. Macrogen Transcriptome Sequencing Models, Specifications and Application
Table 90. Macrogen Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 91. Macrogen Recent Developments
Table 92. Tsingke Biotechnology Co., Ltd. Company Information, Head Office, Market Area and Industry Position
Table 93. Tsingke Biotechnology Co., Ltd. Company Profile and Main Business
Table 94. Tsingke Biotechnology Co., Ltd. Transcriptome Sequencing Models, Specifications and Application
Table 95. Tsingke Biotechnology Co., Ltd. Transcriptome Sequencing Revenue and Gross Margin, 2018-2023
Table 96. Tsingke Biotechnology Co., Ltd. Recent Developments
List of Figure
Figure 1. Transcriptome Sequencing Picture
Figure 2. Global Transcriptome Sequencing Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Transcriptome Sequencing Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Transcriptome Sequencing Market Share of Global
Figure 5. Global Transcriptome Sequencing Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Transcriptome Sequencing Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Transcriptome Sequencing Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Transcriptome Sequencing Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Transcriptome Sequencing Industry Chain
Figure 10. Coding RNA
Figure 11. Noncoding RNA
Figure 12. By Type, Global Transcriptome Sequencing Revenue, 2018-2029, US$ Million
Figure 13. By Type, Global Transcriptome Sequencing Revenue Market Share, 2018-2029
Figure 14. Biomedical Field
Figure 15. Non-medical Field
Figure 16. By Application, Global Transcriptome Sequencing Revenue, 2018-2029, US$ Million
Figure 17. By Application, Global Transcriptome Sequencing Revenue Market Share, 2018-2029
Figure 18. By Region, Global Transcriptome Sequencing Revenue Market Share, 2018-2029
Figure 19. North America Transcriptome Sequencing Revenue & Forecasts, 2018-2029, US$ Million
Figure 20. By Country, North America Transcriptome Sequencing Revenue Market Share, 2018-2023
Figure 21. Europe Transcriptome Sequencing Revenue & Forecasts, 2018-2029, US$ Million
Figure 22. By Country, Europe Transcriptome Sequencing Revenue Market Share, 2018-2023
Figure 23. Asia Pacific Transcriptome Sequencing Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country/Region, Asia Pacific Transcriptome Sequencing Revenue Market Share, 2018-2023
Figure 25. South America Transcriptome Sequencing Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country, South America Transcriptome Sequencing Revenue Market Share, 2018-2023
Figure 27. Middle East & Africa Transcriptome Sequencing Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. U.S. Transcriptome Sequencing Revenue, 2018-2029, (US$ Million)
Figure 29. By Company, U.S. Transcriptome Sequencing Market Share, 2018-2023
Figure 30. By Type, U.S. Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 31. By Application, U.S. Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 32. Europe Transcriptome Sequencing Revenue, 2018-2029, (US$ Million)
Figure 33. By Company, Europe Transcriptome Sequencing Market Share, 2018-2023
Figure 34. By Type, Europe Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 35. By Application, Europe Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 36. China Transcriptome Sequencing Revenue, 2018-2029, (US$ Million)
Figure 37. By Company, China Transcriptome Sequencing Market Share, 2018-2023
Figure 38. By Type, China Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 39. By Application, China Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 40. Japan Transcriptome Sequencing Revenue, 2018-2029, (US$ Million)
Figure 41. By Company, Japan Transcriptome Sequencing Market Share, 2018-2023
Figure 42. By Type, Japan Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 43. By Application, Japan Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 44. South Korea Transcriptome Sequencing Revenue, 2018-2029, (US$ Million)
Figure 45. By Company, South Korea Transcriptome Sequencing Market Share, 2018-2023
Figure 46. By Type, South Korea Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 47. By Application, South Korea Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 48. Southeast Asia Transcriptome Sequencing Revenue, 2018-2029, (US$ Million)
Figure 49. By Company, Southeast Asia Transcriptome Sequencing Market Share, 2018-2023
Figure 50. By Type, Southeast Asia Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 51. By Application, Southeast Asia Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 52. India Transcriptome Sequencing Revenue, 2018-2029, (US$ Million)
Figure 53. By Company, India Transcriptome Sequencing Market Share, 2018-2023
Figure 54. By Type, India Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 55. By Application, India Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 56. Middle East & Asia Transcriptome Sequencing Revenue, 2018-2029, (US$ Million)
Figure 57. By Company, Middle East & Asia Transcriptome Sequencing Market Share, 2018-2023
Figure 58. By Type, Middle East & Asia Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 59. By Application, Middle East & Asia Transcriptome Sequencing Revenue Market Share, 2022 VS 2029
Figure 60. Research Methodology
Figure 61. Breakdown of Primary Interviews
Figure 62. Bottom-up Approaches
Figure 63. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|